Postprandial Glycemic and Physiological Responses to Walking With a Wearable Hip Exoskeleton in Patients With Type 2 Diabetes

This randomized crossover proof-of-concept study evaluated the effects of walking with a wearable hip exoskeleton on postprandial glycemic and physiological responses in patients with type 2 diabetes. Participants completed four experimental conditions: seated control, walking without the wearable hip exoskeleton, walking with the Bot-Fit device in Aqua mode, and walking with the Bot-Fit device in Boost mode. The primary aim was to determine whether walking with the wearable hip exoskeleton alters postprandial glucose responses compared with seated control and conventional walking conditions in patients with type 2 diabetes.

NCT Number	NCT07692802
Lead Sponsor	CHA University Collaborators: Samsung Electronics
Conditions	Type 2 Diabetes Mellitus (T2DM)
Enrollment	14 participants
Start Date	2026-03-02
Primary Completion	2026-05-24 (estimated)
Study Completion	2026-05-24 (estimated)
Updated on ClinicalTrials.gov	2026-07-09